12/10/2024Eli Lilly Plans to Launch Weight Loss Drug in China Soon

12/10/2024China's First Quantum Computing-empowered Medicine Research Institute ...

12/9/2024Domestic Pharma Cos Poised to Gain in Chinese GLP-1 Obesity Drug Marke...

12/9/2024Hengrui Medicine to Issue H-Shares and Pursue Hong Kong Main Board Lis...

12/9/2024CStone Unveils Promising Clinical Data on CS5001 for Advanced Lymphoma...

12/9/2024Nicox Launches Zerviate in China thru OcuMension Therapeutics

12/5/2024GSK and Zhifei Deepen Collaboration to Target RSV Vaccine Development

12/4/2024GSK Secures $1B Option Deal for DualityBio's Preclinical ADC

12/3/2024HUTCHMED and Innovent's ELUNATE and TYVYT Combo Win Chinese Condi...

12/3/2024Signet Thera Secures Over CNY 70M to Advance Targeted Cancer Drug Deve...

12/3/2024NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...

12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...

12/3/2024CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...

12/2/2024UCB Closes Divestment from Neurology and Allergy Portfolio in China, ...

12/2/2024Allink Biotherapeutics Secures $42M Series A to Advance Oncology and I...

12/2/2024Hangzhou Jiuyuan Gene Engineering Debuts on Hong Kong Stock Exchange

12/2/2024Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia

12/2/2024Shanghai Cell Therapy Group Submits Application Proof for Hong Kong Li...

12/2/2024Affinity Biopharma Raises Over CNY 400M in Series B2 to Advance Tumor-...

12/2/2024Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...

12/2/2024Nanjing Leads Biolabs Files for Hong Kong IPO

11/28/2024AstraZeneca's Enhertu Secures Reimbursement Listing Despite Ongoing Pr...

11/28/2024BeOne Secures EU Approval for First-Line Checkpoint Blocker

11/27/2024Policy Change Set to Advance Cell and Gene Therapy in China

11/27/2024Kelun's Merck-partnered TROP2 ADC sac-TMT Approved for Marketing in C...

11/25/2024DP Tech and Lepu Biopharma Enter ADC Partnership

11/25/2024BRL Medicine Secures ~CNY 200M in Series B+ Financing to Advance Gene ...

11/25/2024TG ImmunoPharma Completes Series Pre-A+ Financing to Accelerate Immuno...

11/25/2024Junshi Secures Licensing Deal for Bispecific Fusion Proteins

11/25/2024Hanx Biopharma Submits IPO Application to HKSE

Page:9/21 Total number of articles:605: [First][<<] [7] [8] [9] [10] [11] [>>] [End]